CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 24,717	$ (14,204)	$ 47,283	$ (61,240)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization	27,215	23,466	84,061	67,407
(Gain) loss on disposal of property and equipment and divestitures			(1,905)	1,921
Equity in losses of unconsolidated entities	218	129	576	129
Bad debt expense (recovery)			2,091	(651)
Amortization of debt issuance costs	100	200	539	516
Inventory adjustments	(800)	100	(612)	139
Equity-based compensation			11,023	6,248
Bargain purchase gain	3,273		(13,768)
Unrealized loss on short-term investment				1,406
Other operating items, net			(710)	(309)
Changes in operating assets and liabilities
Accounts receivable			(141,468)	(32,509)
Prepaid expenses and other assets			(200)	(10,284)
Accounts payable and accrued liabilities			10,983	13,331
Net cash used in operating activities			(2,107)	(13,896)
Cash flows from investing activities
Purchase of property and equipment			(50,815)	(29,925)
Investment in note receivable				(1,101)
Purchase of equity-method investments			(6,767)	(2,200)
Collection of note receivable			184
Distribution from cost method investment			60	120
Acquisitions, net of cash and restricted cash received			5,707
Acquisitions, net of cash and restricted cash received				(18,644)
Proceeds received from sales of property and equipment			21,433	6,491
Proceeds received from divestitures			705
Net cash used in investing activities			(29,493)	(45,259)
Cash flows from financing activities
Borrowings from revolving line of credit			82,000
Payments on revolving line of credit			(82,000)
Payments on long-term debt			(18,780)
Payments of finance lease obligations			(108)	(238)
Payment of debt issuance costs			(2,144)
Proceeds from share issuance			35	43
Distributions to noncontrolling interests				(1,074)
Repurchase of common stock			(19,967)	(1,206)
Net cash used in financing activities			(40,964)	(2,475)
Effect of exchange rate changes on cash			(15)	4
Net decrease in cash and cash equivalents			(72,579)	(61,626)
Cash and cash equivalents, beginning of period			85,801	169,039	$ 169,039
Cash and cash equivalents, end of period	$ 13,222	107,413	13,222	107,413	$ 85,801
Supplemental cash flow disclosure:
Cash paid for interest			1,255	1,108
Cash refunds received for income taxes, net			(452)	(927)
Supplemental disclosure of noncash investing activities:
Issuance of shares for acquisitions		$ 20,304	35,854	20,304
Conversion of notes receivable to equity-method investment			4,442
Capital expenditures included in accounts payable and accrued liabilities			$ 19,896	$ 8,433